These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1835056)

  • 1. [Effectiveness of intravenous immunoglobulins in Guillain-Barré syndrome].
    Forrett-Kaminsky MC; Scherer C; Bemer M; Robert V; Steinbach G; Poussel JF
    Presse Med; 1991 Oct; 20(31):1516. PubMed ID: 1835056
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome.
    Rajah A
    Anaesthesia; 1992 Mar; 47(3):220-2. PubMed ID: 1566990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial experiences in the use of intravenous immunoglobulins in Guillain-Barré-Strohl syndrome].
    Ceccarelli M; Pifferi M; Simoni F; Lupetti L; Ughi C
    Pediatr Med Chir; 1987; 9(6):719-21. PubMed ID: 3444744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Huh M; Davis W
    N Engl J Med; 1992 Sep; 327(11):817. PubMed ID: 1501670
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood.
    al-Qudah AA
    J Child Neurol; 1994 Apr; 9(2):178-80. PubMed ID: 8006371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children.
    Vallée L; Dulac O; Nuyts JP; Leclerc F; Vamecq J
    Neuropediatrics; 1993 Aug; 24(4):235-6. PubMed ID: 8232785
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapse in Guillain-Barré syndrome after treatment with human immune globulin.
    Irani DN; Cornblath DR; Chaudhry V; Borel C; Hanley DF
    Neurology; 1993 May; 43(5):872-5. PubMed ID: 8492939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome after renal transplantation: a case of clinical success with intravenous immunoglobulin therapy.
    Bouza-Piñeiro P; Pego R; Alonso A; de la Fuente R; Martul EV
    Nephron; 1996; 74(1):223-4. PubMed ID: 8883048
    [No Abstract]   [Full Text] [Related]  

  • 11. Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment.
    Castro LH; Ropper AH
    Neurology; 1993 May; 43(5):1034-6. PubMed ID: 8492921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of intravenously administered immune serum globulin in patients with Guillain-Barré syndrome.
    Shahar E; Murphy EG; Roifman CM
    J Pediatr; 1990 Jan; 116(1):141-4. PubMed ID: 2295955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of the Guillain-Barre syndrome with intravenous gammaglobulin. Presentation of a case].
    Barriales V; Velasco L; Moral A; Sánchez Navarro J
    Med Clin (Barc); 1990 Mar; 94(10):399. PubMed ID: 1692387
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Raphael JC; Chastang C; Chevret S; Gajdos P
    N Engl J Med; 1992 Sep; 327(11):816; author reply 817. PubMed ID: 1501669
    [No Abstract]   [Full Text] [Related]  

  • 15. The place of high dose immunoglobulins in the treatment of Guillain-Barré patients based upon the dutch trial.
    van der Meché FG
    Wien Klin Wochenschr Suppl; 1991; 190():17-8. PubMed ID: 1771902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do corticosteroids influence the disease course or mortality of Guillain Barre syndrome?
    Mehndiratta MM
    J Assoc Physicians India; 1996 Jun; 44(6):431. PubMed ID: 9282570
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of acute Guillain-Barré syndrome. A national multicenter study].
    Kloss TM; Haupt WF; Philipp T; Diener HC
    Nervenarzt; 1994 Dec; 65(12):881-3. PubMed ID: 7854512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome.
    Farcas P; Avnun L; Frisher S; Herishanu YO; Wirguin I
    Lancet; 1997 Dec; 350(9093):1747. PubMed ID: 9413468
    [No Abstract]   [Full Text] [Related]  

  • 19. Single high-dose intravenous immunoglobulin for treatment of pediatric Guillain-Barré syndrome.
    Wong BL; Glauser TA
    J Child Neurol; 1998 Mar; 13(3):146. PubMed ID: 9535240
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.